abstract |
The invention relates to new arylglycinamide derivatives of general formula I n nand the pharmaceutically acceptable salts thereof, wherein R 1 and R 2 together with the N to which they are bound form a ring of the formulan n nin whichn R 3 , R 4 , R 5 , Ar, R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , r, s and t have the meanings given in the specification and the preparation and use thereof. The new compounds are valuable neurokinin (tachykinin) antagonists. |